University of Maryland Global Campus

BIOT 670R: Biotechnology Capstone: Regulatory Affairs

A guide to UMGC's regulatory affairs capstone, a semester-long team project on a real regulatory problem in biotechnology.

Updated October 2026 · 5 min read

BIOT 670R closes UMGC's biotechnology regulatory affairs concentration with a semester-long team project built on a real regulatory problem.

According to UMGC's catalog, the course is an in-depth exploration of the regulatory affairs field. Students apply their knowledge while demonstrating research, analytical, oral and written communication, teamwork and leadership skills. Projects come from real-world problems from industry, academic institutions and government organizations.

Regulatory work rewards precision. A capstone in this field is judged on whether the team identified the right requirements, read the primary sources correctly and turned them into a practical plan.

Course at a Glance

ItemDetails
UniversityUniversity of Maryland Global Campus (UMGC)
Course codeBIOT 670R
Credits3
Who can take itStudents in the regulatory affairs concentration only
Prerequisite30 credits of program coursework, including all core courses
Credit ruleCredit for only one of BIOT 670, 670I, 670M, 670R or 670S
Typical workTeam project, regulatory analysis, strategy report, presentation

The Kinds of Questions Regulatory Projects Address

Sponsors set the topics, but regulatory affairs problems in biotechnology usually involve questions like these:

Regulatory Concepts Worth Mastering

Classifying the Product First

Everything follows from what the product is. In the United States, the FDA regulates drugs, biologics and medical devices through different routes, and combination products are assigned according to their primary mode of action.

Product typeCommon US routes
New drugIND for clinical trials, then NDA
BiologicIND, then BLA
Medical device510(k), De Novo or PMA, by risk
Engineered crop or microbeCoordinated Framework: USDA, EPA and FDA roles

Strategy, Not Just a Checklist

A regulatory strategy explains the chosen route, the evidence plan, the timeline and the main risks. It also plans contact with the regulator, such as pre-submission meetings, where the agency can comment before major investment.

Example: A start-up has a diagnostic test similar to tests already on the market. The team compares it with existing devices, concludes a 510(k) route is likely, identifies a suitable predicate, lists the performance data needed, and flags the risk that a new intended use could push it towards De Novo instead.

Reading Primary Sources

Regulations, agency guidance documents and official databases are the evidence in this field. Quote them accurately, note the version or date, and avoid relying on secondary summaries.

Typical Deliverables and How to Approach Them

DeliverableWhat it showsHow to approach it
Regulatory landscapeCorrect classificationAgency, pathway and governing rules, cited
Strategy reportPlanning and judgmentRoute, evidence plan, timeline, risks
Gap analysisCompliance readinessRequirement, current state, gap, action
PresentationBriefing decision-makersRecommendation, key risks, next steps

Writing in a Regulatory Style

Regulatory documents are read by reviewers who need facts quickly. Use short declarative sentences, defined terms and consistent abbreviations. Avoid promotional language such as "breakthrough" or "completely safe", which reviewers distrust.

Every claim should point to its evidence: a study, a standard, a regulation or an agency guidance document. Tables summarizing requirements and evidence are easier to check than long paragraphs.

Version control matters too. Regulators expect traceability, so keep a change log in team documents and date every draft. It is a habit worth building before you work in the field.

Comparing Regulators

Many sponsors plan to sell in more than one market. In the European Union, for example, medicines are often authorized through the European Medicines Agency, while medical devices follow the Medical Device Regulation and conformity assessment by notified bodies. Timelines, evidence expectations and terminology differ from the FDA's.

A comparison table of the regions the sponsor cares about, covering pathway, evidence, typical review steps and post-market duties, is often one of the most useful outputs a regulatory capstone team can deliver.

Where Students Get Stuck

Tips for BIOT 670R

How We Help with BIOT 670R

Send the brief, rubric, drafts and feedback. A writer familiar with regulatory documents can help you outline a strategy, check that your classification reasoning is clear, or edit sections for accuracy and style. Our capstone proposal guide covers planning documents in more depth.

GradeEssays is independent of University of Maryland Global Campus. We help you understand and improve your own work; we do not write documents for you to submit as your own or access your course. Every order is written from scratch, with free revisions within the scope of your original request.

Make Your Regulatory Capstone Precise and Defensible

Share the brief, sources and feedback. A writer helps you structure a clear, well-referenced model document.

Start My Capstone Help

Free revisions · Full refund if late · Written from scratch for your order

Frequently Asked Questions

Who can enroll in BIOT 670R?

Students in UMGC's biotechnology regulatory affairs concentration who have completed 30 credits of program coursework, including all core courses.

Can I earn credit for two BIOT 670 capstones?

No. UMGC allows credit for only one of BIOT 670, 670I, 670M, 670R or 670S.

Does the capstone involve real organizations?

Yes. UMGC says projects come from real-world problems supplied by industry, academic institutions and government organizations.

Do I need to cover non-US regulators?

Only if the project calls for it, but many sponsors sell internationally, so comparing regulators can add value.

What sources count as primary in regulatory work?

Regulations, agency guidance documents and official agency databases and decisions.

Can you write our regulatory report?

No. We provide outlines, explanations and editing to support your team's own work.